GPT and hepatocellular carcinoma: They also found that 46.4 % of HBeAg-seropositive patients older than 40 years of age with high risk of HCC, as estimated by a REACH score ≥11, would be erroneously excluded from treatment, mainly because their ALT levels never exceeded 2× ULN, even after frequent blood tests during follow-up.